Characterizing glucose in labor: Continuous glucose monitoring in parturients without diabetes

Current recommendations for intrapartum glycemic control in those with diabetes mellitus are based upon expert opinion. Our objective was to characterize intrapartum interstitial glucose values using continuous glucose monitors (CGMs) in term gravidas without diabetes.A prospective observational cohort of 72 parturients without pre‐gestational or gestational diabetes. CGMs were placed in early labor and the following were obtained: glucose at delivery, mean glucose in active and second stage of labor, time in range defined as 70–120 mg/dL, time above range, and time below range. Glucose parameters were compared by body mass index (BMI) and by adequacy of gestational weight gain. Neonatal outcomes were assessed.The mean glucose value at delivery was 109 ± 27 mg/dL and over the 2 h prior to delivery was 99 ± 23 mg/dL. A total of 26% of parturients had a glucose value > 120 mg/dL at the time of delivery. Mean glucose in active labor was 101 ± 25 mg/dL and in the second stage was 99.5 ± 23 mg/dL. In labor, average time‐in‐range was 69.8% (10th–90th percentile 33.8%–95.8%), time‐above‐range was 19.9% (10th–90th percentile 0%–66.2%), and time‐below‐range was 10.3% (10th–90th percentile 0%–66%). Neither BMI nor gestational weight gain had a significant clinical impact on these parameters. A total of 28 infants had glucose checked for clinical indications and 5 required treatment for neonatal hypoglycemia; this was unrelated to mean glucose during labor or at delivery, time‐above‐range in labor and second stage, and time‐above‐range in the 4 h prior to delivery.Interstitial glucose greater than 120 mg/dL was common, and neither BMI nor gestational weight gain appears to have a significant clinical impact on glucose in labor. These data challenge contemporary definitions of glucose goals in labor, and further study is needed to better define glucose in labor and identify risk factors for adverse outcomes.

• Publication year

  2025

• Venue

  Pregnancy

• Publication date

  2025-09-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1002/pmf2.70108
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Permissive Intrapartum Glucose Control: An Equivalence Randomized Control Trial (PERMIT).

  2024cited by this paper
• 7. Diabetes Technology: Standards of Care in Diabetes-2024.

  2023cited by this paper
• Accuracy of Continuous Glucose Monitoring in Pregnancy During Inpatient Acute Glycemic Variability in Women with Type 1 Diabetes Mellitus

  2022cited by this paper
• Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study

  2022cited by this paper
• Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes

  2019cited by this paper
• A Comparison of Time Delay in Three Continuous Glucose Monitors for Adolescents and Adults

  2017cited by this paper
• Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years

  2017cited by this paper
• Time Delay of CGM Sensors

  2015cited by this paper
• ACOG Committee opinion no. 548: weight gain during pregnancy.

  2013cited by this paper
• Glycemic control in non-diabetic critically ill patients.

  2011cited by this paper
• Blood Glucose Regulation during Prolonged, Submaximal, Continuous Exercise: A Guide for Clinicians

  2010cited by this paper
• Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes.

  2002cited by this paper
• Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.

  1988cited by this paper

• No citing papers are available for this paper.